轉(zhuǎn)化腫瘤學(xué)發(fā)表新研究調(diào)查的結(jié)果，連接實(shí)驗(yàn)室和臨床設(shè)置，包括風(fēng)險(xiǎn)評(píng)估，細(xì)胞和分子特征，預(yù)防，檢測(cè)，診斷和治療人類癌癥的整體目標(biāo)是改善腫瘤患者的臨床護(hù)理。轉(zhuǎn)化腫瘤學(xué)將發(fā)表新的治療干預(yù)措施的實(shí)驗(yàn)室研究，以及評(píng)估癌癥新治療模式的臨床試驗(yàn)。同行評(píng)審的稿件類型包括原始報(bào)告、評(píng)審和社論。

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.